SCHEMBL21547048

SCHEMBL21547048

N#Cc1cccc(-c2cc(-n3c4ccccc4c4ccc5c(c6ccccc6n5-c5ccccc5)c43)c(C#N)c(-n3c4ccccc4c4ccc5c(c6ccccc6n5-c5ccccc5)c43)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
ADORA2A P29274 4/20 0.36
ADORA1 P30542 4/20 0.36
ADORA2B P29275 3/20 0.34
PGR P06401 1/20 0.34
ALDH1A1 P00352 4/20 0.33
LMNA P02545 4/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A3 P47895 1/20 0.33
CYP1A2 P05177 5/20 0.33
CYP3A4 P08684 4/20 0.33
MEN1 O00255 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25903074 0.98 KDM4E (0.37) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL25903340 0.97 KDM4E (0.36) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL25903792 0.96 KDM4E (0.35) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL25903669 0.95 KDM4E (0.35) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL25902944 0.93 KDM4E (0.39) KDM4EATML3MBTL1PGRALDH1A1
SCHEMBL21414303 0.92 KDM4E (0.41) KDM4EATML3MBTL1PGRALDH1A1
SCHEMBL21546486 0.91 KDM4E (0.42) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL25903081 0.91 KDM4E (0.38) KDM4EATML3MBTL1PGRALDH1A1
SCHEMBL21188690 0.90 KDM4E (0.39) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL25903083 0.90 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10981930-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-04-20 US disclosed
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-10 US disclosed
EP-3478793-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-11-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10981930-B2 Organic molecules for use in optoelectronic devices OR10J3, OR51E2, EPCAM KDM4E 4571/4885ATM 3780/4885L3MBTL1 4380/4885
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OR51E2, EPCAM KDM4E 4571/4885ATM 3780/4885L3MBTL1 4380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.